Sabine Maamari
Chief Operating Officer Avocet Bio
Seminars
Thursday 29th January 2026
RNA Editing in the Lung: Programmable Nucleases & Next-Gen Inhaled Delivery for Respiratory Disease
4:00 pm
- Exploring next-generation RNA modalities from programmable nucleases to emerging enzyme systems for therapeutic use in the lung
- Case study: Leveraging a Cas13 platform to counter respiratory viral infections
- Designing inhalable delivery vehicles for safe, efficient deposition throughout the airways
